While the Buy rating suggests that UBS still sees DaVita as a good investment, the reduction in the price target could imply that there are factors that might limit the stock's upside potential in the short term. Investors may view the lowered price target as a sign of tempered expectations, which could have a neutral to slightly negative impact on the stock price in the short term.